The Isometamidium (ISOMETA) mainly used for the rare disease in the cattle, buffalo, goat, sheep, equines (horses, donkeys), camels and dogs. Very few players are manufacturing the said API in India as well as across the world. The company is going to set up a plant with the capacity of 400kg per month API which will be the highest production by any company.
This API plant will increase the revenue of the company by 30-40 Cr p.a. as well as increased the profitability by good %. There is high demand of this API mainly in Middle East, Africa and Latin America. The advance stage negotiation is already going on with buyers for advance order of this API product.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app